锦旗生物：携后生元方案亮相国家中心年会，联合发布《后生元白皮书》

Core Insights - The National Dairy Technology Innovation Center held its third annual conference focusing on technological advancements in the dairy industry, showcasing the latest progress and industrialization achievements in dairy technology [1][2] - The "Postbiotics White Paper" was jointly released, providing authoritative guidance for understanding postbiotics and serving as a critical decision-making tool for R&D and market strategies for companies in the industry [1][2][3] Industry Overview - Postbiotics, defined as non-viable microorganisms and their metabolites, are rapidly gaining traction in the global health food and supplement market, with a projected market size growth from $1.2 billion in 2024 to $4.5 billion by 2031, reflecting a compound annual growth rate (CAGR) of 21.3% [2] - China has made significant progress in postbiotic research, achieving initial results in areas such as gut microbiota regulation, immune enhancement, skin health, and infant nutrition [2] Challenges and Initiatives - The industry faces challenges in the research and industrialization of postbiotics, including a lack of unified definitions and classifications, unclear mechanisms of action, absence of relevant standards, and difficulties in technology transfer [2] - The National Dairy Technology Innovation Center initiated a special technology project in 2022 to systematically advance the field of postbiotics, integrating resources from academia and industry to promote scientific standards and industrial innovation [2] Product Development and Innovation - The conference highlighted the release of the "Postbiotics White Paper," which systematically outlines the scientific connotations, efficacy components, and health effects of postbiotics, focusing on representative strains such as Lactobacillus casei ET-22 and Bifidobacterium longum infantis YLGB-1496 [3] - Jin Qi Biological showcased its evidence-based postbiotic products, including Lactobacillus casei ET-22, which has undergone extensive clinical trials demonstrating its efficacy in oral health [7][10] Company Strategy and Future Plans - Jin Qi Biological has developed a complete industrial chain system for functional probiotics, from strain selection to market production, and aims to leverage global resources from partners like Yili and Ausnutria to enhance its offerings in the health sector [11]